Free Trial

Canopy Growth (TSE:WEED) Stock Price Down 2.6% - Here's Why

Canopy Growth logo with Medical background

Key Points

  • Canopy Growth Corp shares fell by 2.6%, trading between C$1.51 and C$1.52, with a significant drop in trading volume at 1,078,346 shares.
  • ATB Capital has downgraded Canopy Growth's price target from C$3.20 to C$1.60, giving the stock an "underperform" rating.
  • Insider selling activity was noted as Director David Angelo Lazzarato sold 15,701 shares at an average price of C$1.68, indicating a potential lack of confidence from company leadership.
  • Interested in Canopy Growth? Here are five stocks we like better.
  • Limited Time Offer: Unlock powerful research tools, advanced financial data, and expert insights to help you invest with confidence. Save 50% when you upgrade to MarketBeat All Access during the month of July. Claim your discount here.

Canopy Growth Corp (TSE:WEED - Get Free Report) shares traded down 2.6% on Tuesday . The stock traded as low as C$1.51 and last traded at C$1.52. 1,078,346 shares changed hands during trading, a decline of 41% from the average session volume of 1,820,001 shares. The stock had previously closed at C$1.56.

Analyst Ratings Changes

Separately, ATB Capital lowered their target price on shares of Canopy Growth from C$3.20 to C$1.60 and set an "underperform" rating on the stock in a research note on Tuesday, June 3rd.

Read Our Latest Stock Analysis on WEED

Canopy Growth Trading Up 3.6%

The stock has a market cap of C$233.26 million, a P/E ratio of -0.21, a PEG ratio of -0.01 and a beta of 1.79. The company has a current ratio of 1.39, a quick ratio of 2.32 and a debt-to-equity ratio of 120.38. The stock's fifty day moving average price is C$1.82 and its 200 day moving average price is C$2.01.

Insiders Place Their Bets

In other news, Director David Angelo Lazzarato sold 15,701 shares of the company's stock in a transaction dated Monday, June 30th. The shares were sold at an average price of C$1.68, for a total transaction of C$26,307.34. Company insiders own 0.21% of the company's stock.

Canopy Growth Company Profile

(Get Free Report)

Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names.

Further Reading

Should You Invest $1,000 in Canopy Growth Right Now?

Before you consider Canopy Growth, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Canopy Growth wasn't on the list.

While Canopy Growth currently has a Strong Sell rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

The $2.5B Merger No One Is Talking About
ALERT: Big Tech Earnings – Watch Before Wednesday
ACT FAST! Congress is Dumping these 3 Stocks

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines